Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
0.630
-0.009 (-1.49%)
Jun 24, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0 | 0 | 0 | 0 | 0 | 0.14 | 0.18 | 0.36 | 0.15 | 0.19 | Upgrade
|
|
Revenue Growth (YoY)
|
- | - | - | - | - | -19.33% | -51.39% | 141.12% | -19.18% | 19.55% | Upgrade
|
|
Gross Profit
|
0 | 0 | 0 | 0 | 0 | 0.14 | 0.18 | 0.36 | 0.15 | 0.19 | Upgrade
|
|
Selling, General & Admin
|
6.94 | 3.45 | 4.31 | 4.34 | 3.97 | 3.61 | 4.51 | 4.93 | 2.73 | 2.21 | Upgrade
|
|
Research & Development
|
12.64 | 10.45 | 13.31 | 6.92 | 5.94 | 9.83 | 12.56 | 15.39 | 8.5 | 4.51 | Upgrade
|
|
Other Operating Expenses
|
0 | 0.04 | 0.13 | 0.06 | 0.13 | 0.05 | 0.04 | 0.45 | 0.02 | 0.02 | Upgrade
|
|
Operating Expenses
|
19.58 | 13.94 | 17.75 | 11.32 | 10.04 | 13.48 | 17.1 | 20.76 | 11.25 | 6.74 | Upgrade
|
|
Operating Income
|
-19.58 | -13.94 | -17.75 | -11.32 | -10.04 | -13.34 | -16.92 | -20.4 | -11.1 | -6.55 | Upgrade
|
|
Interest Expense / Income
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.02 | 0.01 | Upgrade
|
|
Other Expense / Income
|
-4.27 | -0.48 | -5.41 | -3.06 | -2.49 | -5.61 | -11.04 | -7.1 | -3.33 | -1.32 | Upgrade
|
|
Pretax Income
|
-15.31 | -13.46 | -12.34 | -8.27 | -7.54 | -7.73 | -5.89 | -13.33 | -7.79 | -5.24 | Upgrade
|
|
Net Income
|
-15.31 | -13.46 | -12.34 | -8.27 | -7.54 | -7.73 | -5.89 | -13.33 | -7.79 | -5.24 | Upgrade
|
|
Net Income Common
|
-15.31 | -13.46 | -12.34 | -8.27 | -7.54 | -7.73 | -5.89 | -13.33 | -7.79 | -5.24 | Upgrade
|
|
Shares Outstanding (Basic)
|
1,697 | 895 | 616 | 534 | 534 | 534 | 503 | 428 | 339 | 288 | Upgrade
|
|
Shares Outstanding (Diluted)
|
1,697 | 895 | 616 | 534 | 534 | 534 | 503 | 428 | 339 | 288 | Upgrade
|
|
Shares Change
|
89.62% | 45.32% | 15.34% | - | - | 6.20% | 17.44% | 26.38% | 17.70% | 16.23% | Upgrade
|
|
EPS (Basic)
|
-0.54 | -0.90 | -1.20 | -0.93 | -0.85 | -0.87 | -0.70 | -1.87 | -1.38 | -1.09 | Upgrade
|
|
EPS (Diluted)
|
-0.54 | -0.90 | -1.20 | -0.93 | -0.85 | -0.87 | -0.70 | -1.87 | -1.38 | -1.09 | Upgrade
|
|
Free Cash Flow Per Share
|
-0.61 | -0.63 | -1.36 | -0.71 | -0.66 | -0.83 | -1.30 | -1.90 | -1.41 | -1.43 | Upgrade
|
|
Gross Margin
|
- | - | - | - | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
|
Operating Margin
|
- | - | - | - | - | -9351.45% | -9570.10% | -5607.33% | -7359.72% | -3510.12% | Upgrade
|
|
Profit Margin
|
- | - | - | - | - | -5418.28% | -3327.87% | -3664.14% | -5161.66% | -2806.90% | Upgrade
|
|
Free Cash Flow Margin
|
- | - | - | - | - | -5201.87% | -6163.60% | -3727.38% | -5284.96% | -3681.84% | Upgrade
|
|
EBITDA
|
-15.31 | -13.46 | -12.34 | -8.27 | -7.54 | -7.73 | -5.89 | -13.3 | -7.77 | -5.23 | Upgrade
|
|
EBITDA Margin
|
- | - | - | - | - | -5418.28% | -3327.87% | -3655.90% | -5149.94% | -2800.71% | Upgrade
|
|
EBIT
|
-15.31 | -13.46 | -12.34 | -8.27 | -7.54 | -7.73 | -5.89 | -13.3 | -7.77 | -5.23 | Upgrade
|
|
EBIT Margin
|
- | - | - | - | - | -5418.28% | -3327.87% | -3655.90% | -5149.94% | -2800.71% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from audited reports submitted to the
Securities and Exchange Commission
(SEC).